ALBO - Albireo Pharma Inc. (ALBO) CEO Ron Cooper on Q2 2021 Results - Earnings Call Transcript

Albireo Pharma, Inc. (ALBO) Q2 2021 Earnings Conference Call August 05, 2021 10:00 AM ET Company Participants Paul Arndt - Managing Director of LifeSci Advisors Ron Cooper - President and Chief Executive Officer Simon Harford - Chief Financial Officer Pamela Stephenson - Chief Commercial Officer Christine Clemson - Vice President and Head of Medical Affairs Conference Call Participants Yasmeen Rahimi - Piper Sandler Tim Lugo - William Blair Ritu Baral - Cowen Joseph Stringer - Needham & Company Brian Skorney - Baird Ed Arce - H.C. Wainwright Andreas Argyrides - Wedbush Presentation Operator Good morning, and welcome to the Albireo Pharma Second Quarter 2021 Earnings Call. [Operator Instructions] Please note that this conference is being recorded. I will now turn the call over to your host, Paul Arndt, Managing Director of LifeSci Advisors. Thank you. You may begin. Paul Arndt Thank you, operator, and good morning, everyone. Thank you for

For further details see:

Albireo Pharma, Inc. (ALBO) CEO Ron Cooper on Q2 2021 Results - Earnings Call Transcript